Abound Wealth Management’s ADMA Biologics ADMA Stock Holding History

Abound Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84	Hold	10	–	–	﹤0.01%	1313
2026 Q1	$91	Hold	10	–	–	﹤0.01%	1430
2025 Q4	$183	Hold	10	–	–	﹤0.01%	1211
2025 Q3	$147	Hold	10	–	–	﹤0.01%	1229
2025 Q2	$183	Sell	10 -5	-33%	-$102	﹤0.01%	1067
2025 Q1	$298	Sell	15 -1	-6%	-$17	﹤0.01%	872
2024 Q4	$275	Hold	16	–	–	﹤0.01%	920
2024 Q3	$320	Buy	+16	New	+$249	﹤0.01%	964

Other funds holding ADMA

Ardsley Advisory Partners Stamford, Connecticut $921M AUM 207.76% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Inspirion Wealth Advisors Libertyville, Illinois $873M AUM 16.23% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return